Efficacy Study of Digibind for Treatment of Severe Preeclampsia

NCT00158743 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

51

Enrollment

OTHER

Sponsor class

Conditions

Pre-eclampsia

Interventions

DRUG: Anti-digoxin antibody (FAB fragment)
OTHER: sodium chloride

Sponsor

BTG International Inc.

Collaborators

[object Object]